Conferences and Speeches
BioNJ’s 2026 BioPartnering Conference
| Tuesday, May 12, 2026 |
Morgan Lewis is a sponsor of BioNJ's 2026 BioPartnering Conference. Partner David Schwartz will deliver opening remarks and partner Jacqueline Berman will speak during the event.
Jacqueline will present on the panel Evolving FDA Approval Strategies: Maximizing Value, Minimizing Risk, and Navigating Regulatory Trends in a Changing Landscape on May 12, 2026, from 8:50–9:20 am ET.
As regulatory expectations shift and scrutiny increases across the life sciences sector, companies must rethink traditional pathways to approval.
The panel will explore how innovators can navigate the evolving FDA environment, accelerate time to approval, manage regulatory risk, and align clinical, compliance, and commercial strategies to maximize enterprise value.